Skip to content
To the full analysis

City Therapeutics Stock: Dividend

CTY
$18.35Closing price of 19 Nov 2026MEQIRI Score 58 out of 100

City Therapeutics does not currently pay a dividend. From fiscal 2017 to 2019, City Therapeutics bought back its own shares for $8M.

Whether City Therapeutics Inc. pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.

Daily figure as of 20 Nov 2026

Free Cash Flow and Buybacks

Fiscal yearFree cash flowShare buybacksShares outstanding
2019$2.28B$2M0
2018$2.75B$5M0
2017$1.11B$1M0
2016$1.39B$5M0
2015$1.34B$3M0
Buyback calculator for City Therapeutics

Data and Required Disclosures

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026
  • Price: closing price of 19 Nov 2026
  • Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2019. MEQIRI calculates the score and fair value itself every night.
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.